GlassScriptPhysician profile
Jeffrey Lam
NPI 1851022735
$1,867.47
in general payments reported to CMS, 2019-2025
13 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.70 · 2023: $757 · 2024: $956 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,838.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $796.03 | 2022-2024 | |
| Glaxosmithkline, LLC. | $416.89 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $236.19 | 2023-2024 | |
| Lilly USA, LLC | $83.02 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $82.16 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $68.37 | 2024-2025 | Cologuard Collection Kit |
| Bioventus LLC | $33.30 | 2023-2024 | Durolane, Durolane |
| Takeda Pharmaceuticals U.S.A., INC. | $32.87 | 2023 | Trintellix |
| Fidia Pharma USA INC. | $32.54 | 2023 | Hymovis, Triluron |
| Amgen INC. | $28.43 | 2024 | Otezla, Repatha |
| Myriad Women'S Health, INC. | $22.79 | 2023 | Myrisk |
| Coopersurgical, INC. | $20.47 | 2023 | Paragard T 380a |
| Bausch Health US, LLC | $14.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.